[Asia Economy Reporter Oh Ju-yeon] Since the outbreak of the novel coronavirus infection (COVID-19), the domestic stock market has successfully achieved a V-shaped rebound due to the Chinese government's economic stimulus policies. However, as opinions arise that these stimulus measures are insufficient to revitalize the economy, the stock market has been fluctuating. On the 18th, the domestic stock market saw both the KOSPI and KOSDAQ indices fall by over 1% due to selling by foreign and institutional investors.


On that day, the KOSPI opened at 2225.98, down 0.72% from the previous trading day, but the decline widened, recording 2215.77 (-1.18%) as of 10:23 AM. Foreign investors sold 87.2 billion KRW, institutions sold 257.2 billion KRW, while individuals net bought 336.9 billion KRW.


Among the top market capitalization stocks, all of the top 10 stocks, including Samsung Electronics (-1.95%) and SK Hynix (-2.38%), declined.


The KOSDAQ index also recorded 684.57 during the morning session, down 1.16% from the previous trading day. Individuals purchased 153.7 billion KRW, but foreign and institutional investors sold 82.7 billion KRW and 70.9 billion KRW, respectively.



Among the top market capitalization stocks, Celltrion Healthcare (0.29%) and Pearl Abyss (0.33%) rose, but HLB (-1.00%), CJ ENM (-0.72%), and Studio Dragon (-0.95%) declined.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing